Efficacy of folic acid supplementation on endothelial function and plasma homocysteine concentration in coronary artery disease: A meta-analysis of randomized controlled trials

Experimental and Therapeutic Medicine

Volumn 7, Issue 5, 2014, Pages 1100-1110

  Yi, Xin ^a,b   Zhou, Yanli ^a,b   Jiang, Dingsheng ^a,b   Li, Xiaoyan ^a,b   Guo, Yi ^b   Jiang, Xuejun ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Coronary artery disease; Endothelial function; Folic acid; Homocysteine; Meta analysis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; CYANOCOBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; NITRATE; PLACEBO; TRIACYLGLYCEROL;

ARTICLE; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; COCHRANE LIBRARY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; ENDOTHELIUM CELL; HEART RATE; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTOLIC BLOOD PRESSURE; VITAMIN SUPPLEMENTATION;

EID: 84896881531     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1553     Document Type: Article

References (43)

1. Quyyumi AA: Prognostic value of endothelial function. Am J Cardiol91: 19H-24H, 2003.
2. Weber T, Auer J, O'Rourke MF, et al: Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation109: 184-189, 2004.
3. Gupta SK, Kotwal J, Kotwal A, Dhall A and GargS: Role of homocysteine & MTHFR C677T gene polymorphism as risk factors for coronary artery disease in young Indians. Indian J Med Res135: 506-512, 2012.
4. Vinukonda G, Shaik Mohammad N, Md Nurul JainJ, PrasadChintakindi K and Rama Devi AkellaR: Genetic and environmental influences on total plasma homocysteine and coronary artery disease (CAD) risk among South Indians. Clin Chim Acta405: 127-131, 2009.
5. Lin PT, Huang MC, Lee BJ, Cheng CH, Tsai TP and Huang YC: High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes. Asia Pac J Clin Nutr17: 330-338, 2008.
6. Bleie Ø, Strand E, Ueland PM, Vollset SE, Refsum H, IglandJ, NordrehaugJE and Nygård OK: Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12. Coron Artery Dis22: 270-278, 2011.
7. MacKenzie KE, Wiltshire EJ, Gent R, Hirte C, PiottoL and CouperJJ: Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type1 diabetes mellitus. Pediatrics118: 242-253, 2006.
8. Till U, Röhl P, Jentsch A, et al: Decrease of carotid intima-media thickness in patients at risk to cerebral ischemia after supplementation with folic acid, vitamins B6 and B12. Atherosclerosis181: 131-135, 2005.
9. de Bree A, van Mierlo LA and Draijer R: Folic acid improves vascular reactivity in humans: a meta-analysis of randomized controlled trials. Am J Clin Nutr86: 610-617, 2007.
10. Shirodaria C, Antoniades C, Lee J, et al: Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease. Circulation115: 2262-2270, 2007.
11. Moat SJ, Madhavan A, Taylor SY, et al: High-but not low-dose folic acid improves endothelial function in coronary artery disease. Eur J Clin Invest36: 850-859, 2006.
12. Doshi SN, Moat SJ, Lewis MJ, McDowell IF, GiddingsJC and GoodfellowJ: Short-term high-dose folic acid does not alter markers of endothelial cell damage in patients with coronary heart disease. Int J Cardiol94: 203-207, 2004.
13. Guo H, Chi J, Xing Y and Wang P: Influence of folic acid on plasma homocysteine levels & arterial endothelial function in patients with unstable angina. Indian J Med Res129: 279-284, 2009.
14. Tam WY, Chook P, Qiao M, et al: The efficacy and tolerability of adjunctive alternative herbal medicine (Salviamiltiorrhiza and Puerarialobata) on vascular function and structure in coronary patients. J Altern Complement Med15: 415-421, 2009.
15. Myles PS, Leslie K, Peyton P, et al: Nitrous oxide and perioperative cardiac morbidity (ENIGMA-II) trial: rationale and design. Am Heart J157: 488-494, 2009.
16. Sultan N, Khan MA and Malik S: Effect of folic acid supplementation on homocysteine level in postmenopausal women. J Ayub Med Coll Abbottabad19: 78-81, 2007.
17. Yilmaz H, Sahin S, Sayar N, et al: Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease. Acta Cardiol62: 579-585, 2007.
18. Austen SK, Fassett RG, Geraghty DP and Coombes JS: Folate supplementation fails to affect vascular function and carotid artery intima media thickness in cyclosporin A-treated renal transplant recipients. Clin Nephrol66: 373-379, 2006.
19. Fernández-Miranda C, Yebra M, Aranda JL, GómezP, Martínez J, Núñez V and Gómez de la Cámara A: Effect of folic acid treatment on carotid intima-media thickness of patients with coronary disease. Int J Cardiol118: 345-349, 2007.
20. Chia S, Wilson R, Ludlam CA, Webb DJ, Flapan AD and NewbyDE: Endothelial dysfunction in patients with recent myocardial infarction and hyperhomocysteinaemia: effects of vitamin supplementation. Clin Sci (Lond) 108: 65-72, 2005.
21. Doshi S, McDowell I, Moat S, Lewis M and GoodfellowJ: Folate improves endothelial function in patients with coronary heart disease. Clin Chem Lab Med41: 1505-1512, 2003.
22. Woodman RJ, Celermajer DE, Thompson PL and HungJ: Folic acid does not improve endothelial function in healthy hyperhomocysteinaemic subjects. Clin Sci (Lond) 106: 353-358, 2004.
23. Liem A, Reynierse-Buitenwerf GH, Zwinderman AH, Jukema JW and van Veldhuisen DJ: Secondary prevention with folic acid: effects on clinical outcomes. J Am Coll Cardiol41: 2105-2113, 2003.
24. Willems FF, Aengevaeren WR, Boers GH, BlomHJ and VerheugtFW: Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease. J Am Coll Cardiol40: 766-772, 2002.
25. Doshi SN, McDowell IF, Moat SJ, Payne N, Durrant HJ, Lewis MJ and Goodfellow J: Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation105: 22-26, 2002.
26. Miner SE, Cole DE, Evrovski J, Forrest Q, Hutchison S, Holmes K and Ross HJ: Pyridoxine improves endothelial function in cardiac transplant recipients. J Heart Lung Transplant20: 964-969, 2001.
27. Doshi SN, McDowell IF, Moat SJ, Lang D, NewcombeRG, KredanMB, Lewis MJ and Goodfellow J: Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide? Arterioscler Thromb Vasc Biol21: 1196-1202, 2001.
28. Thambyrajah J, Landray MJ, Jones HJ, McGlynnFJ, Wheeler DC and Townend JN: A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease. J Am Coll Cardiol37: 1858-1863, 2001.
29. Spence JD, Howard VJ, Chambless LE, Malinow MR, Pettigrew LC, Stampfer M and Toole JF: Vitamin Intervention for Stroke Prevention (VISP) trial: rationale and design. Neuroepidemiology20: 16-25, 2001.
30. Chambers JC, Ueland PM, Obeid OA, Wrigley J, RefsumH and KoonerJS: Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine. Circulation102: 2479-2483, 2000.
31. Title LM, Cummings PM, Giddens K, Genest JJ Jr and Nassar BA: Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J Am Coll Cardiol36: 758-765, 2000.
32. Moens AL, Goovaerts I, Claeys MJ and VrintsCJ: Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool? Chest127: 2254-2263, 2005.
33. Yoshida T, Kawano H, Miyamoto S, Motoyama T, Fukushima H, HiraiN and Ogawa H: Prognostic value of flow-mediated dilation of the brachial artery in patients with cardiovascular disease. Intern Med45: 575-579, 2006.
34. Fairfield KM and Fletcher RH: Vitamins for chronic disease prevention in adults: scientific review. JAMA287: 3116-3126, 2002.
35. Verhaar MC, Wever RM, Kastelein JJ, van Dam T, KoomansHA and Rabelink TJ: 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation97: 237-241, 1998.
36. Schwammenthal Y and Tanne D: Homocysteine, B-vitamin supplementation, and stroke prevention: from observational to interventional trials. Lancet Neurol3: 493-495, 2004.
37. Bazzano LA, Reynolds K, Holder KN and He J: Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA296: 2720-2726, 2006.
38. McRae MP: High-dose folic acid supplementation effects on endothelial function and blood pressure in hypertensive patients: a meta-analysis of randomized controlled clinical trials. J Chiropr Med8: 15-24, 2009.
39. Dionisio N, Jardín I, Salido GM and Rosado JA: Homocysteine, intracellular signaling and thrombotic disorders. Curr Med Chem17: 3109-3119, 2010.
40. Crabtree MJ and Channon KM: Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease. Nitric Oxide25: 81-88, 2011.
41. Smulders YM and Stehouwer CD: Folate metabolism and cardiovascular disease. Semin Vasc Med5: 87-97, 2005.
42. Stroes ES, van Faassen EE, Yo M, Martasek P, Boer P, Govers R and Rabelink TJ: Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circ Res86: 1129-1134, 2000.
43. Hyndman ME, Verma S, Rosenfeld RJ, Anderson TJ and Parsons HG: Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function. Am J Physiol Heart Circ Physiol282: H2167-H2172, 2002.